Conclusion: Hydroxychloroquine administration to the hospitalized SARSCoV-2 positive population was associated with an increased need for escalation of respiratory support. There were no benefits of hydroxychloroquine on mortality, lymphopenia, or neutrophil-tolymphocyte ratio improvement.
Check Also
Fazenda Urbana de Curitiba oferece cursos gratuitos em maio
As aulas vão ensinar práticas sustentáveis, com o objetivo de promover o desenvolvimento de uma …